Exhibits

A nurse is collecting data from a client who has pneumonia and a prescription for cefazolin. Which of the following findings should the nurse report to the provider prior to administering the initial dose? (Cliick on the exhibit tabs for additional information about t three tabs that contain separate categories of data.)

Rationale:

A. Place eye covers on the newborn while under the lights: Eye protection is essential during phototherapy to prevent retinal damage from the high-intensity blue light. The covers should be properly fitted and removed only during feedings or when the therapy is paused.

B. Apply an emollient lotion to skin that is exposed to the lights: Emollients are not recommended during phototherapy because they can increase the risk of burns or interfere with light penetration. The newborn’s skin should remain clean and dry to ensure safety and effective treatment.

C. Remove all blankets, clothing and diapers while the newborn is under lights: While minimal clothing is used to expose as much skin as possible, the diaper is typically kept in place to protect the genital area and reduce the risk of contamination. Full removal is not necessary or recommended.

D. Keep the newborn as close to the light source as possible: The distance between the newborn and the phototherapy light should be within manufacturer guidelines. Moving the newborn too close can increase the risk of overheating or skin damage, so positioning must follow safety standards.

Rationale:

A. Docusate: Docusate is a stool softener that does not interfere with coagulation or increase bleeding risk. It is often safely used in clients taking anticoagulants to prevent straining during bowel movements, which is especially important in post-operative or cardiovascular patients.

B. Cimetidine: While cimetidine may interact with some medications metabolized by the liver, it does not significantly affect bleeding risk when used with enoxaparin. However, it should still be used cautiously due to potential drug interactions and altered metabolism.

C. Calcium supplement: Calcium supplements do not interfere with the anticoagulant action of enoxaparin. They are commonly used for bone health and are generally safe, provided they are taken at recommended doses without excessive vitamin D.

D. Garlic: Garlic, especially in supplement form, can have antiplatelet effects and may increase the risk of bleeding when taken with anticoagulants like enoxaparin. Clients should be advised to avoid herbal products like garlic, ginkgo, or ginseng without provider approval.